Finnrick - Ensuring a Safer and More Transparent Supply Chain
Wuhan Wansheng Biotechnology

Wuhan Wansheng Biotechnology
Tirzepatide

Finnrick tested 2 samples of Tirzepatide (GLP-1 and GIP antagonist) from Wuhan Wansheng Biotechnology between 31 Aug 2025 and 1 Sep 2025. Test scores average over 7, no score below 6, and at least 2 tests warrant a tentative Finnrick Rating of A (Great).

Finnrick Rating™
A
GREAT
Tentative Rating
Wuhan Wansheng Biotechnology
Tirzepatide
Tested 2 Samples
Last test 1 Sep 2025

Take Action

Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

All Tirzepatide tests from Wuhan Wansheng Biotechnology

Samples are tested in commercial labs

Tests Count

2

Scores

AVG7.2MIN6.4MAX8.0

Last

1 Sep 2025

First

31 Aug 2025
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
1 Sep 2025View6.460mg65.930mg+9.9%99.86%(no batch ID)No Label / Copper Crimp / Clear CapLab FPublic
31 Aug 2025View8.030mg30.300mg+1.0%99.91%(no batch ID)No Label / Silver Crimp / Black Cap Lab EPublic